CURIRX
Live / Registered — Registered (as of 13 Feb 2024)
What this means for you
Registered since 13 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97657647
- Registration number
- 7303012
- Mark type
- Stylized text
- Filed
- 01 Nov 2022
- Published for opposition
- 28 Nov 2023
- Registered
- 13 Feb 2024
- Attorney of record
- Joshua S. Jarvis, Esq.
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; laboratory research services relating to pharmaceuticals; consulting services in the fields of biotechnology; consulting services in the field of pharmaceutical research and development; consulting services in the field of laboratory testing relating to pharmaceuticals; consulting services in the field of diagnostics, namely, consulting services related to research and development of medical diagnostic reagents; consulting services in the field of pharmacogenetics; scientific laboratory services
Owner
- CuriRx, Inc., Wilmington, MA, US
- CuriRx, Inc., Wilmington, MA, US
- CuriRx, Inc., Wilmington, MA, US
Prosecution history
- 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 28 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Nov 2023 — PUBLISHED FOR OPPOSITION
- 08 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Sept 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Sept 2023 — NON-FINAL ACTION E-MAILED
- 13 Sept 2023 — NON-FINAL ACTION WRITTEN
- 15 Aug 2023 — ASSIGNED TO EXAMINER
- 17 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Nov 2022 — NEW APPLICATION ENTERED